BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24172912)

  • 21. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Petta S; Cammà C; Di Marco V; Alessi N; Barbaria F; Cabibi D; Caldarella R; Ciminnisi S; Licata A; Massenti MF; Mazzola A; Tarantino G; Marchesini G; Craxì A
    Hepatology; 2008 Jul; 48(1):28-37. PubMed ID: 18506842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
    McPherson S; Anstee QM; Henderson E; Day CP; Burt AD
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):652-8. PubMed ID: 23325287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
    Angulo P; Alba LM; Petrovic LM; Adams LA; Lindor KD; Jensen MD
    J Hepatol; 2004 Dec; 41(6):943-9. PubMed ID: 15582127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease.
    Nobili V; Alisi A; Torre G; De Vito R; Pietrobattista A; Morino G; De Ville De Goyet J; Bedogni G; Pinzani M
    Transl Res; 2010 Oct; 156(4):229-34. PubMed ID: 20875899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.
    Yilmaz Y; Alahdab YO; Yonal O; Kurt R; Kedrah AE; Celikel CA; Ozdogan O; Duman D; Imeryuz N; Avsar E; Kalayci C
    Metabolism; 2010 Sep; 59(9):1327-30. PubMed ID: 20096896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease.
    García-Monzón C; Lo Iacono O; Crespo J; Romero-Gómez M; García-Samaniego J; Fernández-Bermejo M; Domínguez-Díez A; Rodríguez de Cía J; Sáez A; Porrero JL; Vargas-Castrillón J; Chávez-Jiménez E; Soto-Fernández S; Díaz A; Gallego-Durán R; Madejón A; Miquilena-Colina ME
    Eur J Clin Invest; 2014 Jan; 44(1):65-73. PubMed ID: 24134687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease.
    Nobili V; Siotto M; Bedogni G; Ravà L; Pietrobattista A; Panera N; Alisi A; Squitti R
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):370-5. PubMed ID: 23154483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
    Vongsuvanh R; George J; McLeod D; van der Poorten D
    J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
    Ekstedt M; Franzén LE; Mathiesen UL; Kechagias S
    Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis.
    Joka D; Wahl K; Moeller S; Schlue J; Vaske B; Bahr MJ; Manns MP; Schulze-Osthoff K; Bantel H
    Hepatology; 2012 Feb; 55(2):455-64. PubMed ID: 21993925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
    Hossain N; Afendy A; Stepanova M; Nader F; Srishord M; Rafiq N; Goodman Z; Younossi Z
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1224-9, 1229.e1-2. PubMed ID: 19559819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
    Alkhouri N; Morris-Stiff G; Campbell C; Lopez R; Tamimi TA; Yerian L; Zein NN; Feldstein AE
    Liver Int; 2012 Feb; 32(2):297-302. PubMed ID: 22097893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome.
    Yilmaz Y; Senates E; Ayyildiz T; Colak Y; Tuncer I; Ovunc AO; Dolar E; Kalayci C
    Eur J Clin Invest; 2012 Apr; 42(4):411-8. PubMed ID: 21913918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
    Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
    Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
    Park GJ; Wiseman E; George J; Katelaris PH; Seow F; Fung C; Ngu MC
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1411-6. PubMed ID: 21557768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.